Hydrogen bonding properties of the ω side chain of TXA2 antagonists in the binding domain of the TXA2 receptor.

被引：0
|
作者：
Meier, GP
Taylor, DM
Halushka, PV
机构：
[1] Med Univ S Carolina, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1999年 / 218卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
36-MEDI
引用
收藏
页码：U922 / U922
页数：1
相关论文
共 50 条
  • [1] DEVELOPMENTS OF TXA2 ANTAGONISTS
    HAMANAKA, N
    [J]. ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 : 663 - 665
  • [2] ACUTE REDUCTION OF TXA2 PLATELET BINDING-SITES AFTER INVIVO ADMINISTRATION OF A TXA2 RECEPTOR INHIBITOR
    MODESTI, PA
    COLELLA, A
    CECIONI, I
    GENSINI, GF
    ABBATE, R
    SERNERI, GGN
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04) : 439 - 443
  • [3] The presence of the TXA2 receptor in lipid rafts of platelets is necessary for platelet activation by TXA2
    Moscardo, Antonio
    Valles, Juana
    Madrid, Isabel
    Latorre, Ana
    Dasi, Angeles
    Teresa Santos, Maria
    [J]. THROMBOSIS RESEARCH, 2012, 130 : S103 - S103
  • [4] Antiplatelet action of losartan involves TXA2 receptor antagonism but not TXA2 synthase inhibition
    Chlopicki, S
    Koda, M
    Chabielska, E
    Buczko, W
    Gryglewski, RJ
    [J]. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2000, 51 (04): : 715 - 722
  • [5] THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE (TXA2/PG-END) RECEPTOR-BINDING PROPERTIES IN HUMAN PLATELETS OF RIDOGREL, A COMBINED TXA2 SYNTHASE INHIBITOR - TXA2/PG-END RECEPTOR ANTAGONIST
    HEYLEN, L
    DECLERCK, F
    SOMERS, Y
    LEYSEN, JE
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1991, 2 (05) : 617 - 621
  • [6] SYNTHESES OF NEW TXA2/PGH2-RECEPTOR ANTAGONISTS AND THEIR BIOLOGICAL PROPERTIES
    DEICKE, P
    KLAR, U
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (09) : 1063 - 1068
  • [7] Hydrogen bond interactions of a series of N-substituted TXA2 receptor antagonists
    Taylor, DM
    Halushka, PV
    Meier, GP
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2003, 38 (11-12) : 1015 - 1024
  • [8] STRUCTURAL HOMOLOGIES AMONG THROMBOXANE (TXA2) RECEPTOR ANTAGONISTS - MINIMAL PHARMACOPHORIC REQUIREMENTS FOR HIGH-AFFINITY INTERACTION WITH TXA2 RECEPTORS
    LADOUCEUR, G
    MAIS, DE
    JAKUBOWSKI, JA
    UTTERBACK, BG
    ROBERTSON, DW
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (03) : 173 - 178
  • [9] Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity
    Higuchi, W
    Fuse, I
    Hattori, A
    Aizawa, Y
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, 82 (05) : 1528 - 1531
  • [10] THE ROLE OF TXA2 IN HYPERTENSION
    TAUBE, C
    HOHLER, H
    LORENZ, S
    FORSTER, W
    [J]. BIOMEDICA BIOCHIMICA ACTA, 1984, 43 (8-9) : S208 - S211
12345